Targeting innate immune mediators in type 1 and type 2 diabetes

MY Donath, CA Dinarello… - Nature Reviews …, 2019 - nature.com
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …
被引用次数：320 相关文章

Targeting innate immune mediators in type 1 and type 2 diabetes.

MY Donath, CA Dinarello… - Nature reviews …, 2019 - sonar.ch
English Type 1 and type 2 diabetes are characterized by chronic inflammation; both
diseases involve pancreatic islet inflammation, while systemic low-grade inflammation is a …

Targeting innate immune mediators in type 1 and type 2 diabetes.

MY Donath, CA Dinarello… - Nature Reviews …, 2019 - go.gale.com
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …

Targeting innate immune mediators in type 1 and type 2 diabetes.

MY Donath, CA Dinarello… - Nature reviews …, 2019 - europepmc.org
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …

Targeting innate immune mediators in type 1 and type 2 diabetes

MY Donath, CA Dinarello… - Nature reviews …, 2019 - pubmed.ncbi.nlm.nih.gov
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …

[引用][C] Targeting innate immune mediators in type 1 and type 2 diabetes

MY Donath, CA Dinarello… - Nature Reviews …, 2019 - cir.nii.ac.jp
Targeting innate immune mediators in type 1 and type 2 diabetes | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …